Furthermore, depletion of B and T cells mitigated the antitumor effects of FGL1 and LAG-3 inhibition, suggesting that FGL1 contributes to tumor growth by inhibiting antitumor immunity (3). This evidence concerns the gene FGL1 and neoplasm.